IART Integra LifeSciences Holdings Corporation

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026

PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the  following the call.

About Integra LifeSciences

Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard products and solutions is trusted by healthcare professionals to improve patient outcomes. For the latest news and information about Integra and its products, please visit

Investor Relations:

Chris Ward

(609) 772-7736

Media Contact:

Laurene Isip

(609) 208-8121

Integra LifeSciences Holdings Corporation



EN
09/02/2026

Underlying

IARTIntegra LifeSciences Holdings Corporation

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financi...

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) --   (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Reported revenues were $434.9 million, representing a decrease of 1.7% on a reported basis and 2.5% on an organic basis compared to the fourth quarter of 2024. GAAP earnings per diluted share were $(0.02), compared to $0.25 in the fourth quarter of 2024.Adjusted earnings per diluted shar...

February 26, 2026 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Announces Key Executive Leadership Appointments

Integra LifeSciences Announces Key Executive Leadership Appointments Executive team further strengthened with appointments of Teshtar Elavia to the newly created chief technology officer role, Michael Hutchinson as chief legal officer, and Kerri DiPietro as chief quality officer, representing decades of experience in the MedTech industry PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead...

February 17, 2026 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financi...

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026 PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on th...

February 9, 2026 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Mor...

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m ET or 11:15 a.m PT A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under . Abo...

January 5, 2026 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Leadership to Present at the Citi 2025 Global Hea...

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under . About Integra LifeSciencesAt Integra LifeSc...

December 1, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch